STERIS’ (TSE:STE – Free Report) – Equities research analysts at Raymond James issued their FY2027 earnings per share estimates for shares of STERIS’ in a research report issued to clients and investors on Wednesday, March 12th. Raymond James analyst M. Barth forecasts that the company will earn $0.63 per share for the year. Raymond James also issued estimates for STERIS’’s FY2028 earnings at $0.66 EPS.
Other equities analysts also recently issued reports about the stock. Cormark upgraded shares of STERIS’ to a “moderate buy” rating in a research note on Monday, January 6th. Atb Cap Markets upgraded shares of STERIS’ to a “strong-buy” rating in a research note on Sunday, December 22nd.
STERIS’ Price Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
See Also
- Five stocks we like better than STERIS’
- What Are Treasury Bonds?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- What is a buyback in stocks? A comprehensive guide for investors
- 3 Must-Own Stocks to Build Wealth This Decade
- How to Plot Fibonacci Price Inflection Levels
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
